Cargando…

Immunization with Pneumocystis recombinant KEX1 induces robust and durable humoral responses in immunocompromised non-human primates

Infection with the opportunistic fungal pathogen, Pneumocystis jirovecii causes life-threatening pneumonia in immunocompromised individuals. In addition to HIV-1 infected patients, individuals at risk of Pneumocystis infection include those receiving immunosuppressive therapies due to transplantatio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cobos Jiménez, Viviana, Rabacal, Whitney, Rayens, Emily, Norris, Karen A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2019
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6773377/ https://www.ncbi.nlm.nih.gov/pubmed/31348719 http://dx.doi.org/10.1080/21645515.2019.1631135

Ejemplares similares

A therapeutic vaccine strategy to prevent Pneumocystis pneumonia in an immunocompromised host in a non-human primate model of HIV and Pneumocystis co-infection
por: Rabacal, Whitney, et al.
Publicado: (2022)

Statin treatment prevents the development of pulmonary arterial hypertension in a nonhuman primate model of HIV-associated PAH
por: Rabacal, Whitney, et al.
Publicado: (2019)

Vaccine-Induced Protection in Two Murine Models of Invasive Pulmonary Aspergillosis
por: Rayens, Emily, et al.
Publicado: (2021)

Relationship of Pneumocystis antibody responses to paediatric asthma severity
por: Rayens, Emily, et al.
Publicado: (2021)

Nocardiosis in Immunocompromised Patients on Alternative Pneumocystis Prophylaxis
por: Puing, Alfredo G., et al.
Publicado: (2021)

Massive Cavitation by Pneumocystis jirovecii in an Immunocompromised Patient
por: Chaar-Hernandez, Aldair, et al.
Publicado: (2022)

Enhanced Production of Recombinant Secretory Proteins in Pichia pastoris by Optimizing Kex2 P1’ site
por: Yang, Song, et al.
Publicado: (2013)

Application of real time polymerase chain reaction targeting kex 1 gene & its comparison with the conventional methods for rapid detection of Pneumocystis jirovecii in clinical specimens
por: Revathy, Mani, et al.
Publicado: (2014)

Immunogenicity and protective efficacy of a pan-fungal vaccine in preclinical models of aspergillosis, candidiasis, and pneumocystosis
por: Rayens, Emily, et al.
Publicado: (2022)

Demographic and Socioeconomic Factors Associated with Fungal Infection Risk, United States, 2019
por: Rayens, Emily, et al.
Publicado: (2022)

Pneumocystis jirovecii dihydropteroate synthase gene mutations in a group of HIV-negative immunocompromised patients with Pneumocystis pneumonia
por: LONG, YINGJIAO, et al.
Publicado: (2014)

Simultaneous bilateral pneumothorax in an immunocompromised HIV patient with Pneumocystis jirovecii pneumonia
por: Matesanz López, Cristina, et al.
Publicado: (2018)

Is It Possible to Differentiate Pneumocystis jirovecii Pneumonia and Colonization in the Immunocompromised Patients with Pneumonia?
por: Aguilar, Yudy A., et al.
Publicado: (2021)

Trends in the Epidemiology of Pneumocystis Pneumonia in Immunocompromised Patients without HIV Infection
por: Xue, Ting, et al.
Publicado: (2023)

Prevalence and Healthcare Burden of Fungal Infections in the United States, 2018
por: Rayens, Emily, et al.
Publicado: (2022)

Humoral Immune Responses to Pneumocystis jirovecii Antigens in HIV-Infected and Uninfected Young Children with Pneumocystis Pneumonia
por: Djawe, Kpandja, et al.
Publicado: (2013)

Posttranslational processing of the prohormone-cleaving Kex2 protease in the Saccharomyces cerevisiae secretory pathway
Publicado: (1991)

The cell death protease Kex1p is essential for hypochlorite-induced apoptosis in yeast
por: Carmona-Gutierrez, Didac, et al.
Publicado: (2013)

Concurrent COVID-19 and Pneumocystis jirovecii pneumonia in a severely immunocompromised 25-year-old patient
por: Bhat, Pavan, et al.
Publicado: (2020)

Colonization of Pneumocystis jirovecii in Chronic Obstructive Pulmonary Disease (COPD) patients and the rate of Pneumocystis pneumonia in Iranian non-HIV(+) immunocompromised patients
por: Sheikholeslami, Maryam Fatemeh, et al.
Publicado: (2013)

Pneumocystis Pneumonia: Immunity, Vaccines, and Treatments
por: Gingerich, Aaron D., et al.
Publicado: (2021)

Loss of Kex2 Affects the Candida albicans Cell Wall and Interaction with Innate Immune Cells
por: Gómez-Gaviria, Manuela, et al.
Publicado: (2020)

Molecular Modification of Kex2 P1’ Site Enhances Expression and Druggability of Fungal Defensin
por: Jin, Yanjie, et al.
Publicado: (2023)

Evaluation of Loop-Mediated Isothermal Amplification Assay for the Detection of Pneumocystis jirovecii in Immunocompromised Patients
por: Singh, Preeti, et al.
Publicado: (2015)

Multiple nodular lesions following Pneumocystis pneumonia in a non‐HIV immunocompromised patient
por: Asakura, Takanori, et al.
Publicado: (2016)

Pneumocystis pneumonia in children – the relevance of chemoprophylaxis in different groups of immunocompromised and immunocompetent paediatric patients
por: Zajac-Spychała, Olga, et al.
Publicado: (2015)

Relationship between Radiological Stages and Prognoses of Pneumocystis Pneumonia in Non-AIDS Immunocompromised Patients
por: Mu, Xiang-Dong, et al.
Publicado: (2016)

Concurrent Infection with SARS-CoV-2 and Pneumocystis jirovecii in Immunocompromised and Immunocompetent Individuals
por: Gioia, Francesca, et al.
Publicado: (2022)

AN UNEXPECTED RECURRENCE: A CASE OF PNEUMOCYSTIS JIROVECI AND SARS-COV-2 IN AN IMMUNOCOMPROMISED PATIENT
por: PALACIOS, CARLOS, et al.
Publicado: (2022)

Enhancing breadth and durability of humoral immune responses in non-human primates with an adjuvanted group 1 influenza hemagglutinin stem antigen
por: Swart, Maarten, et al.
Publicado: (2023)

Immunolocalization of Kex2 protease identifies a putative late Golgi compartment in the yeast Saccharomyces cerevisiae
Publicado: (1991)

Expression of ustR and the Golgi protease KexB are required for ustiloxin B biosynthesis in Aspergillus oryzae
por: Yoshimi, Akira, et al.
Publicado: (2016)

Outcome and prognostic factors of Pneumocystis jirovecii pneumonia in immunocompromised adults: a prospective observational study
por: Gaborit, Benjamin Jean, et al.
Publicado: (2019)

Quantitative PCR to Discriminate Between Pneumocystis Pneumonia and Colonization in HIV and Non-HIV Immunocompromised Patients
por: Sarasombath, Patsharaporn T., et al.
Publicado: (2021)

Using Routine Laboratory Markers and Immunological Indicators for Predicting Pneumocystis jiroveci Pneumonia in Immunocompromised Patients
por: Tang, Guoxing, et al.
Publicado: (2021)

Supplementary Role of Immunological Indicators in the Diagnosis and Prognosis of Pneumocystis Pneumonia in Non-HIV Immunocompromised Patients
por: Cao, Yaoqian, et al.
Publicado: (2022)

Metagenomic Next-Generation Sequencing Is Highly Efficient in Diagnosing Pneumocystis Jirovecii Pneumonia in the Immunocompromised Patients
por: Wang, Dongsheng, et al.
Publicado: (2022)

A Case Report of Purtscher-Like Retinopathy Secondary to Pneumocystis jirovecii Pneumonia in an Immunocompromised Patient
por: Bezzina, Alastair David, et al.
Publicado: (2022)

Humoral and cellular response to the COVID-19 vaccine in immunocompromised children
por: Morgans, Heather A., et al.
Publicado: (2022)

A combined adjuvant approach primes robust germinal center responses and humoral immunity in non-human primates
por: Phung, Ivy, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_1fqu4cos2qlbruih0327cj3ve3